Oropouche is a virus transmitted by mosquito bites, primarily by the Culicoides paraensis.
Discovered in 1955 in Trinidad and Tobago, the virus has been identified in various regions of Latin America, including Brazil, Peru, Colombia, Ecuador, and more.
Recently, there has been an increase in cases, with notable outbreaks in Brazil and Cuba, and cases have also been detected in Europe, generally in people who traveled to affected areas.
How is it transmitted?
- Mosquito bite: Primarily by the Culicoides paraensis.
- No direct person-to-person transmission. Although possible mother-to-fetus transmission has been investigated, more studies are needed.
Symptoms
The symptoms of Oropouche are similar to those of other mosquito-borne viral diseases, such as dengue:
In some cases, the symptoms may persist or reappear weeks after the initial infection.
Severity and Fatal Cases: Recently, the first deaths from Oropouche have been confirmed in Brazil, alarming health authorities. Additionally, there are concerns about possible adverse effects during pregnancy, such as brain defects in newborns, though more research is needed to confirm these risks.
Treatment and Prevention: Currently, there are no vaccines or specific medications to treat Oropouche. Treatment focuses on managing symptoms, such as using pain relievers and fever reducers. Prevention centers on avoiding mosquito bites by using repellents, protective clothing, and eliminating standing water where mosquitoes can breed.
Challenges and Future: The lack of research and specific treatment measures for Oropouche, along with the increase in cases due to urbanization, deforestation, and climate change, presents a significant challenge. The virus’s expansion into new areas and its integration into urban transmission cycles is an emerging public health concern. More efforts are needed to improve diagnosis, treatment, and prevention to contain the spread of the virus.
Complications
While most people recover completely, in some cases, severe complications may occur, such as:
- Encephalitis: Inflammation of the brain.
- Meningitis: Inflammation of the meninges, the membranes covering the brain and spinal cord.
- Congenital defects: Cases of microcephaly have been reported in babies born to mothers infected during pregnancy, though more studies are needed to confirm this association.
Why is it concerning?
- No vaccine or specific treatment: To date, there is no vaccine or specific antiviral treatment for Oropouche. Treatment focuses on relieving symptoms.
- Increase in cases: Significant outbreaks have been recorded in several Latin American countries, especially in Brazil, where thousands of cases have been reported in recent years.
- Risk factors: Deforestation, climate change, and urbanization favor the proliferation of transmitting mosquitoes and increase the risk of transmission.
Prevention
The best way to prevent Oropouche virus infection is by avoiding mosquito bites:
- Use of repellents: Apply insect repellent to exposed skin.
- Protective clothing: Wear long-sleeved shirts and long pants, especially outdoors.
- Screens on doors and windows: Install screens to prevent mosquitoes from entering homes.
- Eliminate mosquito breeding sites: Remove objects that collect standing water, such as old tires, cans, and flower vases.
What to do if infection is suspected?
If you experience the symptoms mentioned, it is important to consult a doctor as soon as possible. Diagnosis is made through laboratory tests.
In summary, the Oropouche virus represents a growing threat to public health in Latin America. Prevention and vector control are essential to reduce the risk of transmission.
Image: BBC
